CAMBRIAN BIOPHARMA
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
CAMBRIAN BIOPHARMA
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
160 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Euro
Similar Organizations
Arbor Biotechnologies
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Omniome
Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.
Current Advisors List
Current Employees Featured
Founder
Investors List
Future Ventures
Future Ventures investment in Series C - Cambrian Biopharma
SALT Fund
SALT Fund investment in Series C - Cambrian Biopharma
Alumni Ventures
Alumni Ventures investment in Series C - Cambrian Biopharma
Anthos Capital
Anthos Capital investment in Series C - Cambrian Biopharma
Apeiron Investment Group
Apeiron Investment Group investment in Series C - Cambrian Biopharma
infinitas capital group
infinitas capital group investment in Series C - Cambrian Biopharma
Kliwla Family Office AG
Kliwla Family Office AG investment in Series C - Cambrian Biopharma
Moore Capital
Moore Capital investment in Series C - Cambrian Biopharma
infinitas capital group
infinitas capital group investment in Series B - Cambrian Biopharma
Mike Novogratz
Mike Novogratz investment in Series B - Cambrian Biopharma
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-19 | Oviva Therapeutics | Cambrian Biopharma investment in Seed Round - Oviva Therapeutics | 11.5 M USD |
| 2021-06-23 | Vita Therapeutics | Cambrian Biopharma investment in Series A - Vita Therapeutics | 32 M USD |
| 2021-04-13 | Arcellx | Cambrian Biopharma investment in Series C - Arcellx | N/A |
| 2021-01-11 | Sensei Biotherapeutics | Cambrian Biopharma investment in Series B - Sensei Biotherapeutics | 30 M USD |
| 2020-10-07 | Sensei Biotherapeutics | Cambrian Biopharma investment in Series A - Sensei Biotherapeutics | 28.5 M USD |
Newest Events participated